Patterns of metastasis from a multicenter cohort of metastatic basal cell carcinoma - 14/05/24
Doi : 10.1016/j.jaad.2024.01.069
Morgan Groover, BS a, Neha Gupta, MD, MPH a, Emily Granger, BS a, Vernon J. Forrester, MD b, Emily J. Anstadt, MD, PhD c, William Su, MD c, Lauren Heusinkveld, MD b, John N. Lukens, MD c, Ann W. Silk, MD, MS d, Jonathan D. Schoenfeld, MD, MPH e, Shlomo A. Koyfman, MD f, Allison T. Vidimos, RPh, MD b, Emily S. Ruiz, MD a, ⁎ 
a Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts
b Department of Dermatology, Cleveland Clinic, Cleveland Clinic Lerner College of Medicine, Cleveland, Ohio
c Department of Radiation Oncology, University of Pennsylvania, Philadelphia, Pennsylvania
d Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts
e Department of Radiation Oncology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts
f Department of Radiation Oncology, Cleveland Clinic, Cleveland Clinic Lerner College of Medicine, Cleveland, Ohio
∗Correspondence to: Emily S. Ruiz, MD, Associate Professor of Dermatology, Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, 1153 Centre St, Suite 4J, Jamaica Plain, Boston, MA 02130Department of DermatologyBrigham and Women's HospitalHarvard Medical School1153 Centre StSuite 4JJamaica PlainBostonMA02130
Key words : cutaneous oncology, metastatic basal cell carcinoma, patterns of metastasis
| Funding sources: Supported in part by the Melvin Markey Discovery Fund at Cleveland Clinic. |
|
| Patient consent: Not applicable. |
|
| IRB approval status: Reviewed and exempt from approval. |
© 2024
American Academy of Dermatology, Inc.. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 90 - N° 6
P. 1252-1254 - juin 2024 Retour au numéro
Article précédent
- Association of atopic dermatitis with emotional and behavioral problems in childhood
- Emily Z. Ma, Stephen R. Hooper, Paige L. Seegan, Joy Wan
- Efficacy of brodalumab in moderate-to-severe plaque psoriasis after failure of previous biologic therapy: A phase 4, multicenter, open-label study
- Kim Papp, Vimal H. Prajapati, Catherine Maari, Mark Legault, Maxime Barakat, Ronald Vender
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?